Akari Therapeutics Plc - stock earnings
AKTX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q2 | -1499 USD | ? USD |
| 2023Q1 | -1499 USD | ? USD |
| 2022Q4 | -3445 USD | ? USD |
| 2022Q3 | -3445 USD | ? USD |
| 2022Q2 | -5.5 million USD | ? USD |
| 2022Q1 | -5.1 million USD | ? USD |
| 2021Q4 | -5.6 million USD | ? USD |
| 2021Q3 | -1.4 million USD | ? USD |
| 2021Q2 | -4.4 million USD | ? USD |
| 2021Q1 | -5.8 million USD | ? USD |
| 2020Q4 | -6.8 million USD | ? USD |
| 2020Q3 | 1.4 million USD | ? USD |
| 2020Q2 | -8.3 million USD | ? USD |
| 2020Q1 | -3.4 million USD | ? USD |
| 2019Q4 | -7.9 million USD | ? USD |
| 2019Q3 | -2.6 million USD | ? USD |
| 2019Q2 | -4.1 million USD | ? USD |
| 2019Q1 | -3.5 million USD | ? USD |
| 2018Q4 | -3.5 million USD | ? USD |
| 2018Q3 | -3.6 million USD | ? USD |
| 2018Q2 | -9.3 million USD | ? USD |
| 2018Q1 | -1.3 million USD | ? USD |
| 2017Q4 | -1.3 million USD | ? USD |
| 2017Q3 | -10.4 million USD | ? USD |
| 2017Q2 | -320016 USD | ? USD |
| 2017Q1 | -12.6 million USD | ? USD |
| 2016Q4 | -8.3 million USD | ? USD |
| 2016Q3 | -418116 USD | ? USD |
| 2016Q2 | -6.5 million USD | ? USD |
| 2016Q1 | -3.0 million USD | ? USD |
| 2015Q4 | 6.5 million USD | ? USD |
| 2015Q3 | -48.7 million USD | ? USD |
| 2015Q2 | -1.7 million USD | ? USD |
| 2015Q1 | -2.3 million USD | ? USD |
| 2014Q4 | -8.8 million USD | 102000 USD |
| 2014Q3 | -223129 USD | ? USD |
| 2014Q2 | -2.2 million USD | ? USD |
| 2014Q1 | -1.7 million USD | ? USD |
AKTX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -7.0 million USD | ? USD |
| 2021 | -17.6 million USD | ? USD |
| 2020 | -17.6 million USD | ? USD |
| 2019 | -21.8 million USD | ? USD |
| 2018 | -27.9 million USD | ? USD |
| 2017 | -27.9 million USD | ? USD |
| 2016 | -18.1 million USD | ? USD |
| 2015 | -45.3 million USD | ? USD |
| 2014 | -9.6 million USD | ? USD |
| 2013 | -3.6 million USD | ? USD |
| 2012 | -1.4 million USD | ? USD |
| 2011 | -2.1 million USD | ? USD |
| 2010 | -675000 USD | ? USD |
AKTX
Price: $1.18
52 week price:
Earnings Per Share: -2.04 USD
P/E Ratio: -1
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 16739
Ebitda: -8.5 millionMarket Capitalization: 9.6 million